What are Neurocrine Biosciences's profit margins?

Neurocrine Biosciences (NBIX) runs a 98.2% gross margin and a 25.4% operating margin, with a 21.6% net margin.

Where do Neurocrine Biosciences's ratios come from?

Every ratio is computed from Neurocrine Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Neurocrine Biosciences NBIX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	393.2%-0.3pp	393.6%-0.4pp	393.9%-0.2pp	394.1%+0.2pp	393.9%+0.5pp
Operating margin	87.3%+4.9pp	82.4%-2.6pp	85%-5.3pp	90.3%-5.6pp	95.8%-2.9pp
Net margin	68.1%+8.9pp	59.2%+2.2pp	57%-1.3pp	58.2%-2.1pp	60.4%-6.0pp
Returns
Return on equity	67.2%+10.1pp	57.2%+2.2pp	54.9%-1.4pp	56.3%-2.2pp	58.5%-5.7pp
Return on invested capital	56.6%+5.1pp	51.5%-0.8pp	52.3%-5.6pp	57.9%-5.9pp	63.8%-5.5pp
Efficiency
Asset turnover	2.8×0.0×	2.7×0.0×	2.7×0.0×	2.8×0.0×	2.8×0.0×
Liquidity
Current ratio	12.9×-0.2×	13.1×0.0×	13.1×-1.0×	14.1×-1.0×	15.1×+0.6×
Leverage
Debt-to-equity	0.6×-0.1×	0.7×0.0×	0.7×+0.1×	0.7×+0.1×	0.6×0.0×
Net debt / EBITDA	0.5×-0.3×	0.8×-0.8×	1.6×+0.3×	1.3×+0.2×	1.1×+0.5×
Per Share
Book value per share	$120.67+7.3%	$112.46+6.4%	$105.69+3.2%	$102.46+2.5%	$99.93+1.7%
Valuation
Market capitalization	$53.97B+4.2%	$51.78B+0.6%	$51.46B+4.7%	$49.15B-2.1%	$50.2B-5.2%
Price / earnings	118.3×-16.3×	134.6×-10.9×	145.5×+2.4×	143.1×-4.1×	147.2×-1.2×
Price / sales	19.4×-0.3×	19.8×-0.9×	20.7×0.0×	20.7×-1.4×	22.1×-2.4×
Price / book	17.6×-0.5×	18×-1.0×	19×+0.4×	18.7×-0.8×	19.4×-1.4×
EV / EBITDA	86.7×-5.2×	91.9×-2.2×	94.1×+5.1×	88.9×-0.1×	89×-6.7×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Neurocrine Biosciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Neurocrine Biosciences's profit margins?: Neurocrine Biosciences (NBIX) runs a 98.2% gross margin and a 25.4% operating margin, with a 21.6% net margin.
Where do Neurocrine Biosciences's ratios come from?: Every ratio is computed from Neurocrine Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.